These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20001639)

  • 1. Sickle cell disease at the dawn of the molecular era.
    Abboud MR; Musallam KM
    Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
    Kato GJ; Gladwin MT
    JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
    Morris CR
    Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
    Conran N; Franco-Penteado CF; Costa FF
    Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease, vasculopathy, and therapeutics.
    Kassim AA; DeBaun MR
    Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment.
    Pavan AR; Terroni B; Dos Santos JL
    Nitric Oxide; 2024 Aug; 149():7-17. PubMed ID: 38806107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
    Jison ML; Gladwin MT
    Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
    Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
    Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia.
    Sullivan KJ; Kissoon N; Gauger C
    Pediatr Crit Care Med; 2008 Mar; 9(2):159-68. PubMed ID: 18477929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.
    Kato GJ; Hebbel RP; Steinberg MH; Gladwin MT
    Am J Hematol; 2009 Sep; 84(9):618-25. PubMed ID: 19610078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion.
    Montes RA; Eckman JR; Hsu LL; Wick TM
    Am J Hematol; 2002 Jul; 70(3):216-27. PubMed ID: 12111767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular hemolysis and the pathophysiology of sickle cell disease.
    Kato GJ; Steinberg MH; Gladwin MT
    J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte adhesion in sickle cell disease.
    Parise LV; Telen MJ
    Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in clinical research in sickle cell disease.
    Hagar W; Vichinsky E
    Br J Haematol; 2008 May; 141(3):346-56. PubMed ID: 18341629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.